Northwest Biotherapeutics (NWBO) EBT Margin (2010 - 2026)
Northwest Biotherapeutics (NWBO) recorded EBT Margin of -1662.21% in Q2 2026, up 11013.37 percentage points from -12675.57% a year earlier and up 1019.17 percentage points from the prior quarter.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) EBT Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Northwest Biotherapeutics' EBT Margin came in at -2749.70% as of Jun 30, 2026, up 3958.34 percentage points year-over-year; for FY2025, it was -4404.86%, up 1657.22 percentage points from FY2024.
- Annual EBT Margin has a five-year change of +2965.32 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at -6062.08% in FY2024 (-2917.73 pp), -3144.36% in FY2023 (+1207.93 pp), -4352.29% in FY2022 (+1390.30 pp) and -5742.59% in FY2021 (+1627.59 pp).
- The Q2 2026 figure is the highest quarterly EBT Margin since Q1 2023.
- On a year-over-year basis, EBT Margin has increased for three consecutive quarters, with an average year-over-year change of +264.13 percentage points over the last eight quarters.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 21400.66 percentage points in Q3 2021, against a drop of 8921.65 percentage points in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -2681.38% (Q1 2026), -2403.27% (Q4 2025) and -8470.50% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Northwest Biotherapeutics | 250.40 Mn | 240.41 Mn | - | -1,662.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,662.21% |
| Mar 31, 2026 | -2,681.38% |
| Dec 31, 2025 | -2,403.27% |
| Sep 30, 2025 | -8,470.50% |
| Jun 30, 2025 | -12,675.57% |
| Mar 31, 2025 | -5,043.47% |
| Dec 31, 2024 | -9,085.28% |
| Sep 30, 2024 | -4,728.57% |
| Jun 30, 2024 | -3,753.92% |
| Mar 31, 2024 | -6,078.17% |
| Dec 31, 2023 | -3,681.80% |
| Sep 30, 2023 | -3,816.50% |
| Jun 30, 2023 | -7,402.49% |
| Mar 31, 2023 | -1,589.89% |
| Dec 31, 2022 | -3,249.41% |
| Sep 30, 2022 | -8,315.53% |
| Jun 30, 2022 | -4,723.48% |
| Mar 31, 2022 | -3,520.84% |
| Sep 30, 2021 | -3,329.43% |
| Jun 30, 2021 | -3,176.44% |
API Access
Northwest Biotherapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();